192 related articles for article (PubMed ID: 23065261)
1. Prognostic impact of Metadherin-SND1 interaction in colon cancer.
Wang N; Du X; Zang L; Song N; Yang T; Dong R; Wu T; He X; Lu J
Mol Biol Rep; 2012 Dec; 39(12):10497-504. PubMed ID: 23065261
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
[TBL] [Abstract][Full Text] [Related]
3. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
[TBL] [Abstract][Full Text] [Related]
4. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
[TBL] [Abstract][Full Text] [Related]
5. Correlated overexpression of metadherin and SND1 in glioma cells.
Tong L; Wang C; Hu X; Pang B; Yang Z; He Z; He M; Wei L; Chu M
Biol Chem; 2016 Jan; 397(1):57-65. PubMed ID: 26351803
[TBL] [Abstract][Full Text] [Related]
6. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
7. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
[TBL] [Abstract][Full Text] [Related]
8. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction.
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
[TBL] [Abstract][Full Text] [Related]
13. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract][Full Text] [Related]
14. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract][Full Text] [Related]
15. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
Li WF; Wang G; Zhao ZB; Liu CA
Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
17. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
Liu DC; Yang ZL
Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue.
Su P; Zhang Q; Yang Q
Diagn Pathol; 2010 Jun; 5():38. PubMed ID: 20565850
[TBL] [Abstract][Full Text] [Related]
20. SND1 expression in breast cancer tumors is associated with poor prognosis.
Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
